August 15 Product : AstraZenecas Imfinzi Indication : Perioperative non-small cell lung cancer AstraZeneca won a new indication for Imfinzi on Thursday when the FDA green lit the drug, along with platinum-containing chemotherapy, for the perioperative treatment of non-small cell lung cancer (NSCLC)
Mechanism of Action Glucose Homeostasis: Enhances insulin secretion, suppresses glucagon release Gastric Motility: Delays emptying, promotes satiety signals Cardiovascular: Improves endothelial function, reduces inflammation Neuroprotection: Activates survival pathways, reduces neuroinflammation Renal Protection: Reduces albuminuria, preserves kidney function Hepatic: Improves steatosis, reduces liver inflammation Research Advantages Extended Half-Life: Hours vs
We look forward to seeing you soon
Christle Guevarra and Nathalia discuss the surge in GLP-1 prescriptionseven among those who dont need them
But with a drug this potent, the bodys response can be more complex than simple appetite suppression